Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan.
about
Antibiotic treatment for Helicobacter pylori: Is the end coming?Chinese Helicobacter pylori vaccine: Solution for an old challenge?Pharmacological therapy used in the elimination of Helicobacter pylori infection: a reviewFirst-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype.Esomeprazole- or rabeprazole-based triple therapy eradicated Helicobacter pylori comparably regardless of clarithromycin susceptibility and CYP2C19 genotypesReal-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey).The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy.Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial.Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin.Comment on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin".Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease
P2860
Q26777623-B764CC23-31FC-45F7-A0D8-3C3DBA050421Q28077515-66613531-14EA-4E40-B4A9-A61F7FD9FDCAQ28085016-B4CFAD6F-8CC8-43E6-BDB9-9A583B240ACCQ36401615-CD412032-7EBF-435F-89C1-F1059A95F1FEQ37247036-2F357E86-F7AD-4157-91D3-EB6C9421DC19Q40314735-1DC68259-B36F-4EAD-8346-161450A64A3DQ40672521-80B21211-4615-44A7-A900-4FFD1A4D3A96Q47672283-03A29C70-C174-4DD1-861B-8920A43451A4Q47995761-27FC7DD1-D21D-4F50-8B2B-7DBBCCFF571AQ52575016-794CAD6A-A82F-4FED-B2C5-ABDDFC87E083Q57284272-2B64CA82-175A-43FA-AE22-339B4CD750F8
P2860
Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparative study of esomepraz ...... Helicobacter pylori in Japan.
@en
Comparative study of esomepraz ...... Helicobacter pylori in Japan.
@nl
type
label
Comparative study of esomepraz ...... Helicobacter pylori in Japan.
@en
Comparative study of esomepraz ...... Helicobacter pylori in Japan.
@nl
prefLabel
Comparative study of esomepraz ...... Helicobacter pylori in Japan.
@en
Comparative study of esomepraz ...... Helicobacter pylori in Japan.
@nl
P2093
P2860
P356
P1476
Comparative study of esomepraz ...... Helicobacter pylori in Japan.
@en
P2093
Akira Takeda
Atsuo Inoue
Hideki Iijima
Hirohisa Tanimura
Hiroyuki Fukui
Hiroyuki Ogawa
Ichizo Kobayashi
Makoto Ichiba
Mamoru Yura
Masahide Oshita
P2860
P304
P356
10.3748/WJG.V20.I15.4362
P407
P577
2014-04-01T00:00:00Z